Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Change of Website Address

8 Jan 2020 07:00

RNS Number : 0638Z
Asimilar Group PLC
08 January 2020
 

 

Asimilar Group plc

("Asimilar" or the "Company")

£6.8 million Equity Placing at 40 pence per share with Warrants

Asimilar Group Plc, the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), is pleased to announce that it has raised £6.8 million (gross) of new equity by way of a placing (the "Placing") of 17,000,000 new Ordinary Shares in the Company (the "Placing Shares") at a price of 40 pence per Ordinary Share with existing and new investors.

A warrant will be issued for every Placing Share subscribed for as part of the Placing exercisable at 130 pence per Ordinary Share from the date of issue up to 31 December 2021 ("Warrant"), with an accelerated exercise provision in the event that the mid-market price for Asimilar's Ordinary Shares reaches 280 pence per Ordinary Share for 5 consecutive business days. The Warrants will be required to be exercised within 21 calendar days of such an event or otherwise will lapse. Exercise of all the Warrants in the Company issued as part of the Placing would raise a further £22.1 million for the Company.

Investors that have committed to subscribe for Placing Shares include Nigel Wray and Chris Akers.

The proceeds of the Placing (after expenses) will be used, in conjunction with the funds currently held by Asimilar, to pursue the Company's investing policy of focusing on technology opportunities in the fields of big data, machine learning, telematics and the internet of things. The Company is currently actively considering a number of potential investment opportunities some of which may, or may not, lead to a reverse takeover at some time in the future.

Following completion of the Placing, Asimilar expects to have net cash available for investment of approximately £9.3 million.

The Placing will complete in 2 tranches, the first of which will complete on or around Friday 24 January 2020 and the second will complete on or around 13 March 2020.

Tranche 1

The £4,000,000 subscription monies payable for 10,000,000 of the Placing Shares ("Tranche 1 Placing Shares") are payable on 24 January 2020. Application will be made to the London Stock Exchange for the Tranche 1 Placing Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission of the Tranche 1 Placing Shares will become effective on or around 24 January 2020. 

Tranche 2

The £2,800,000 subscription monies payable for 7,000,000 of the Placing Shares ("Tranche 2 Placing Shares") are payable on 13 March 2020. Application will be made for admission of the Tranche 2 Placing Shares and it is expected that admission of the Tranche 2 Placing Shares will become effective on or around 13 March 2020.

All the Placing Shares will rank pari passu with the Company's existing Ordinary Shares in all respects.

Total Voting Rights

The current issued share capital of the Company is 82,132,276 Ordinary Shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Following the admission of the 11,562,500 Ordinary Shares issued pursuant to the placing announced on 18 December 2019 on or around 20 January 2020, the total issued share capital of the Company will be 93,694,776 Ordinary Shares, each with voting rights.

Following the admission of the 10,000,000 Tranche 1 Placing Shares on or around 24 January 2020, the total issued share capital of the Company will be 103,694,776 Ordinary Shares, each with voting rights.

Following the admission of the 7,000,000 Tranche 2 Placing Shares on or around 13 March 2020, the total issued share capital of the Company is expected to be 110,694,776 Ordinary Shares, each with voting rights.

As part of the Placing, Nigel Wray, who currently holds 12.19% of the issued share capital in the Company, has subscribed for 1,875,000 Ordinary Shares. Following admission of the Tranche 1 Placing Shares, he will hold approximately 11.5% of the issued share capital. Nigel Wray's participation in the Placing is considered to be a related party transaction under the AIM Rules for Companies. The Directors, having consulted with the Company's Nominated Adviser, consider that the terms of the participation of Mr Wray in the Placing are fair and reasonable insofar as the Company's shareholders are concerned.

New Website

Following the change of name announced on 23 December 2019, the Company's website address has been changed to www.asimilargroup.com.

 

John Taylor, Chairman of the Company said:

"We are excited by this premium equity placing which facilitates considerably greater capital flexibility for Asimilar to pursue a select number of potentially bold and transformative investment options. We look forward to keeping shareholders updated on our progress over the coming period".

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

**ENDS**

Enquiries

Asimilar Group plc

 

John Taylor, Non-Executive Chairman

via Wallbrook

 

 

Cairn Financial Advisers LLP

 

Sandy Jamieson, Liam Murray

Tel: +44 20 7213 0880

 

 

Peterhouse Capital Limited

 

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

 

 

Walbrook PR Ltd

Tel: +44 20 7933 8787

Paul McManus

Mob: +44 7980 541 893

Nick Rome

Mob: +44 7748 325 236

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKDLFBBFLEBBK
Date   Source Headline
23rd Jun 20087:00 amRNSInterim Results
9th Jun 200812:00 pmRNSContract Win
19th Mar 20082:29 pmRNSDirector/PDMR Shareholding
17th Mar 20082:22 pmRNSPosting of annual report
29th Feb 20087:01 amRNSContract gains
27th Feb 20089:27 amRNSHolding(s) in Company
26th Feb 20081:58 pmRNSDirector/PDMR Shareholding
25th Feb 20082:21 pmRNSAGM Statement
6th Feb 20087:01 amRNSAdditional Listing & Placing
31st Jan 20083:35 pmRNSFinal Results
6th Nov 20075:40 pmRNSDirectorate Change
15th Oct 20077:00 amRNSBlue chips trial product
8th Oct 20077:01 amRNSSignificant contract gain
28th Sep 20077:02 amRNSContract Gains
21st Sep 20077:01 amRNSSignificant contract gain
10th Sep 20077:02 amRNSPrivate Placing
17th Aug 20079:07 amRNSRule 26 compliance
13th Aug 20077:00 amRNSContract gains
6th Aug 20077:00 amRNSNew distributor
29th Jun 20077:01 amRNSInterim Results
22nd Jun 20077:01 amRNSContract gains
15th Jun 20077:01 amRNSContract gain
23rd May 20077:01 amRNSBoard Change
14th May 200711:22 amRNSAGM Statement
11th May 20077:01 amRNSNew product launch
23rd Apr 20077:02 amRNSAppointment of Distributors
20th Apr 20075:47 pmRNSDirector/PDMR Shareholding
19th Apr 20077:01 amRNSContract gain
4th Apr 20077:03 amRNSGrowing presence in the USA
29th Mar 200712:15 pmRNSFinal Results
19th Jan 200711:29 amRNSTotal Voting Rights
22nd Dec 200610:06 amRNSTotal Voting Rights
6th Dec 20066:41 pmRNSIssue of Equity
10th Nov 20067:00 amRNSRe Contract
3rd Nov 20067:00 amRNSRe Contract
27th Oct 20067:01 amRNSRe Contract
26th Sep 20061:10 pmRNSIssue of Equity
22nd Sep 20067:00 amRNSContract wins
31st Jul 20067:00 amRNSContract gain
24th Jul 20067:01 amRNSInvestment
15th Jun 20063:05 pmRNSIssue of Equity
14th Jun 20067:01 amRNSInterim Results
6th Jun 20067:01 amRNSContract gain
15th May 200611:37 amRNSDisposal
18th Apr 20067:01 amRNSBoard changes
31st Mar 20063:36 pmRNSAnnual Report and Accounts
31st Mar 200610:37 amRNSFinal Results
24th Feb 20067:00 amRNSCompany Restructure
8th Dec 20057:00 amRNSBahrain office & contract win
25th Nov 20057:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.